BRITNEY CASCIELLO: Open Payments
NPI 1609448182 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,027 in 105 payments from 23 companies in 2025. Trend: 2023 $2,142 · 2024 $2,123 · 2025 $2,027
Food & beverage: $2,027
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 15 | $309 |
| Amgen Inc. | 13 | $247 |
| SCPHARMACEUTICALS INC. | 9 | $241 |
| E.R. Squibb & Sons, L.L.C. | 22 | $230 |
| BridgeBio Pharma, Inc. | 3 | $166 |
| Merck Sharp & Dohme LLC | 9 | $139 |
| Alnylam Pharmaceuticals Inc. | 6 | $107 |
| Novo Nordisk Inc | 5 | $101 |
| Providence Medical Technology, Inc. | 1 | $87 |
| United Therapeutics Corporation | 3 | $63 |
Products named: Repatha, FUROSCIX, Attruby, ONYX FRONTIER, CAMZYOS, MICRA, VERQUVO, ELIQUIS.
Industry payments across NC — which companies pay providers there.
